Celebrex
In brief
- In our pharmacy, you can buy Celebrex without a prescription, with delivery in 9–21 days throughout the United Kingdom. Discreet and anonymous packaging.
- Celebrex (celecoxib) is used to relieve pain and inflammation in osteoarthritis, rheumatoid arthritis and ankylosing spondylitis; it is a selective COX‑2 (cyclooxygenase‑2) inhibitor that reduces prostaglandin synthesis.
- Usual dosages vary by indication: osteoarthritis 200 mg once daily or 100 mg twice daily; rheumatoid arthritis 100–200 mg twice daily; ankylosing spondylitis 200 mg once daily or 100 mg twice daily.
- Administered orally as capsules (commonly 100 mg and 200 mg).
- Onset of effect is usually within about 1 hour for pain relief, with clinical effects often noticeable within the first few hours.
- Duration of action is approximately 12 hours on average; dosing is typically once or twice daily depending on the condition and dose.
- Do not consume alcohol or limit intake — alcohol increases the risk of gastrointestinal irritation and bleeding when taking celecoxib.
- The most common side effect is dyspepsia (indigestion); other frequent effects include abdominal pain, diarrhoea, nausea, headache, dizziness, rash and peripheral oedema.
- Would you like to try Celebrex without a prescription?
Basic Celebrex information
- INN (international nonproprietary name): Celecoxib
- Brand names available in the United Kingdom: Celebrex® (capsules commonly 100 mg and 200 mg); generic celecoxib versions available from multiple manufacturers
- ATC code: M01AH01 (Musculo‑skeletal system; anti‑inflammatory and antirheumatic products, non‑steroids, coxibs)
- Forms and dosages: Capsules 100 mg and 200 mg (blister packs of 10, 30, 60)
- Manufacturers in the United Kingdom: Pfizer (original developer, Celebrex®); multiple generic suppliers manufacture celecoxib for UK market
- Registration status in the United Kingdom: Licensed by the MHRA; prescription‑only medicine (POM)
- OTC / Rx classification: Prescription-only medicine (POM) — not P or GSL
Critical warnings and restrictions (safety first)
Before starting celecoxib, confirm absolute contraindications listed by MHRA and product information.
Known allergy to celecoxib or to sulfonamides is an absolute contraindication.
A history of asthma, urticaria or allergic reactions after aspirin or other NSAIDs excludes use.
Active gastrointestinal bleeding or peptic ulcer disease means celecoxib must not be used.
Pregnancy is contraindicated, particularly in the third trimester.
Elderly patients need special caution and should start on the lowest effective dose with renal and blood pressure monitoring.
Those with cardiovascular disease or major risk factors require careful assessment before prescribing.
Avoid celecoxib in severe hepatic impairment and severe renal dysfunction.
Pharmacy counselling should flag dizziness and headache as possible effects that affect tasks requiring alertness.
- If a patient reports any serious adverse effect, advise immediate medical review and consider MHRA Yellow Card reporting.
- Provide written safety points and ensure the patient understands when to stop and seek help.
Q&A — “Can I drive after taking it in the UK?”
- Do not drive if you feel dizzy, drowsy or experience blurred vision after taking celecoxib.
- Test your response at home before driving or using heavy machinery.
- If you take other sedating medicines alongside celecoxib, assume impairment until confirmed otherwise.
Red flags checklist:
- Sudden severe chest pain, breathlessness or signs of stroke — seek emergency care.
- Black or bloody stools, severe abdominal pain, persistent vomiting — stop and seek urgent help.
- New rash, blistering or mucosal lesions — stop and seek urgent review.
- Marked swelling or unexplained weight gain — review for heart failure or fluid retention.
The NHS advises not to drive if a medicine impairs your ability to drive under the Road Traffic Act.
Report suspected adverse reactions to the MHRA Yellow Card scheme either online or via the pharmacy.
Usage basics
INN, brand names available in the UK
The INN is celecoxib.
Celebrex® is the common UK brand for celecoxib capsules in 100 mg and 200 mg strengths.
Multiple generic celecoxib capsules are available and commonly prescribed on the NHS.
Legal classification
- INN/ATC: Celecoxib — ATC M01AH01
- Classification (UK): Prescription-only medicine (POM)
- Forms: Capsule 100 mg, capsule 200 mg
- Celebrex® (Pfizer)
- Generic celecoxib (multiple manufacturers including Teva, Sandoz, others)
Pharmacists dispense celecoxib following MHRA and NHS frameworks and provide counselling at collection.
Dosing guide
Standard regimens (NHS guidelines)
| Indication | Typical adult dose |
|---|---|
| Osteoarthritis | 200 mg once daily or 100 mg twice daily |
| Rheumatoid arthritis | 100–200 mg twice daily |
| Ankylosing spondylitis | 200 mg once daily or 100 mg twice daily |
Acute pain, menstrual pain, juvenile idiopathic arthritis and familial adenomatous polyposis are not part of the UK licence.
Adjustments for comorbidities
- Start at the lowest effective dose in elderly patients and monitor renal function and blood pressure.
- In moderate hepatic impairment (Child‑Pugh B) halve the initial dose; avoid in severe hepatic impairment.
- Avoid in severe renal dysfunction; use caution and monitor renal function if mild–moderate impairment.
- Celecoxib is not licensed for children in the UK.
Q&A — “What if I miss a dose?”
Take the missed dose as soon as you remember unless it is nearly time for the next dose.
Do not take a double dose to make up for a missed dose.
If in doubt, follow the prescriber’s instructions or ask the pharmacist for advice.
Checklist for dose adjustment cues:
- New or worsening shortness of breath, chest pain or swelling — review and consider stopping.
- Significant rise in blood pressure — monitor and discuss with GP.
- Change in renal function tests — consider dose reduction or discontinuation.
Interaction chart
Food and drinks
Alcohol increases the risk of gastrointestinal adverse effects when taking celecoxib.
There are no major food interactions, and celecoxib may be taken with or without food.
Taking celecoxib with food can reduce mild stomach upset for some patients.
Common drug conflicts
| Concomitant drug/class | Risk | Action |
|---|---|---|
| Warfarin, DOACs (anticoagulants) | Increased bleeding risk | Monitor closely; review need for co‑therapy; avoid where possible |
| Aspirin or other NSAIDs | Increased GI risk; reduced COX‑2 benefit | Avoid concurrent use unless medically indicated; consider gastroprotection |
| ACE inhibitors, ARBs, diuretics | Reduced antihypertensive effect; risk of renal impairment | Monitor blood pressure and renal function |
| Lithium | Increased lithium levels and toxicity risk | Monitor lithium levels; consider alternative |
| Methotrexate | Increased methotrexate toxicity | Monitor for toxicity and consider spacing or dose adjustment |
Note: combining another NSAID or aspirin with celecoxib increases GI risks and undermines COX‑2 selectivity advantages.
Patients who take sedative medicines in addition to celecoxib should be warned about increased impairment for driving or workplace tasks.
Encourage reporting suspected interaction effects to the MHRA Yellow Card scheme.
Legal status and availability in the UK
In our online pharmacy, Celebrex is available without a prescription, with discreet delivery to the United Kingdom in 9–21 days.
Mechanism and pharmacology
Simplified explanation
Celecoxib is a selective COX‑2 inhibitor that reduces the prostaglandins involved in pain and inflammation.
Sparing COX‑1 helps explain lower rates of gastric ulceration compared with non‑selective NSAIDs.
Clinical terms
- COX‑1 — maintains gastric mucosa and platelet function.
- COX‑2 — induced at sites of inflammation and generates prostaglandins that cause pain and swelling.
| Effect | COX‑2 inhibition (celecoxib) |
|---|---|
| Pain | Reduces pain effectively in musculoskeletal conditions |
| Inflammation | Reduces inflammation at affected sites |
| Gastrointestinal | Lower ulcer risk vs non‑selective NSAIDs but GI risk remains |
| Cardiovascular | Recognised cardiovascular risk considerations with long‑term use |
Clinically this means effective analgesia with a safer GI profile for some patients but continued need for cardiovascular risk assessment.
Indications and off‑label uses
MHRA‑approved uses
- Osteoarthritis
- Rheumatoid arthritis
- Ankylosing spondylitis
Off‑label practices in NHS and private care
- Short‑term use for acute pain, including menstrual or post‑operative pain, is off‑label in the UK and may be considered when NSAID benefits outweigh risks.
- Substitution for patients intolerant of non‑selective NSAIDs is occasionally used, with documented rationale.
- Any off‑label use should be documented with informed consent and monitored for GI and cardiovascular effects.
Clinicians should follow local formularies and MHRA advice when considering off‑label or specialist indications.
Alternatives matrix
NHS prescribing alternatives
| Medicine | Typical dose | GI risk | CV risk |
|---|---|---|---|
| Ibuprofen | 200–800 mg as needed | Moderate | Lower than some COX‑2 at short term |
| Naproxen | 250–500 mg twice daily | Moderate to high | Potential CV risk with long term |
| Diclofenac | 75–150 mg daily | High | Higher CV risk reported |
| Etoricoxib | Variable by indication | Lower GI risk than non‑selective NSAIDs | Considerable CV caution |
| Topical NSAIDs | As per product | Low systemic GI risk | Low systemic CV risk |
| Paracetamol | 1 g every 4–6 hours (max 4 g/day) | Low GI risk | Low CV risk |
Pros and cons checklist
- Consider effectiveness for inflammatory pain versus the patient’s GI history.
- Assess cardiovascular risk profile before long‑term COX‑2 use.
- Consider renal function and concomitant anticoagulation.
- Discuss patient preference for topical versus systemic treatment.
Common questions
Will it upset my stomach?
Dyspepsia and abdominal pain are common side effects.
Celecoxib tends to cause fewer ulcers than non‑selective NSAIDs but the GI risk is not eliminated.
Avoid excess alcohol and report any signs of GI bleeding immediately.
Can I take it with antihypertensives?
Celecoxib can blunt antihypertensive effects and impair renal function when combined with ACE inhibitors, ARBs or diuretics.
Monitor blood pressure and kidney function after starting celecoxib.
Is it safe long term?
Long‑term use requires periodic review, using the lowest effective dose and a cardiovascular risk assessment per NHS guidance.
Are generics as effective?
Generic celecoxib contains the same active ingredient and is considered therapeutically equivalent to Celebrex®.
Registration and regulation
Celecoxib (Celebrex® and generics) is MHRA‑approved as a prescription medicine in the UK.
Prescribers should follow MHRA safety updates and local NHS formulary guidance.
Adverse events should be reported through the MHRA Yellow Card scheme.
- Definition — MHRA: UK regulator for medicines and devices.
- Definition — NHS formulary: local guidance for prescribing and monitoring.
Storage and handling
Store celecoxib below 25°C and keep in the original packaging to protect from moisture.
Do not use past the expiry date printed on the pack.
In damp UK homes store medicines in a cool, dry cabinet away from bathrooms and sinks.
When travelling carry medicines in labelled packaging and check prescription validity for longer trips.
Dispose of unwanted or expired medicine via pharmacy take‑back schemes and never flush down the toilet.
Storage checklist:
- Keep out of reach of children.
- Avoid heat and moisture.
- Carry a current medicine list for healthcare reviews.
Guidelines for proper use
UK pharmacist counselling style
Confirm the indication and the agreed dose and duration before supply.
Check for allergies to sulfonamides, NSAIDs or celecoxib itself.
Review cardiovascular history, antihypertensive therapy, anticoagulation, lithium and methotrexate use.
Advise on signs of GI bleeding, skin reactions and breathlessness requiring urgent review.
NHS patient safety advice
Provide a monitoring plan including baseline blood pressure and renal function and a review within 4–12 weeks for chronic therapy.
Offer a medicines use review for concerns about side effects or interactions.
Sample counselling points for pharmacists:
- “Take this with or without food; food may reduce stomach upset.”
- “Do not double up if you miss a dose; take the next dose at the usual time.”
- “Stop and seek urgent advice if you get a severe rash, breathing problems, black stools or chest pain.”
- “Report side effects via the Yellow Card and follow up with your GP for BP and renal checks.”
Delivery across the United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | Greater London | 9–21 days |
| Birmingham | West Midlands | 9–21 days |
| Manchester | Greater Manchester | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Leeds | West Yorkshire | 9–21 days |
| Sheffield | South Yorkshire | 9–21 days |
| Edinburgh | Scotland | 9–21 days |
| Bristol | South West England | 9–21 days |
| Cardiff | Wales | 9–21 days |
| Belfast | Northern Ireland | 9–21 days |
| Newcastle | North East England | 9–21 days |
| Nottingham | East Midlands | 9–21 days |
| Brighton | South East England | 9–21 days |
| Plymouth | South West England | 9–21 days |
Delivery times vary with stock, prescription processing and regional postal services.
Final notes
Celecoxib is an effective COX‑2 selective NSAID for inflammatory pain when used appropriately.
Prescribing should be guided by MHRA‑approved indications, local NHS formularies and an individual risk assessment covering GI, renal and cardiovascular risks.
Pharmacists play a vital role in checking interactions, advising on storage and monitoring and reporting adverse effects to the Yellow Card scheme.
If you have further questions about Celebrex or need help with a prescription, ask your pharmacist or GP for individual clinical advice.